Nicotine pouches under the microscope: will they help or harm rural ohio?

NCT ID NCT05730439

Completed Knowledge-focused Sponsor: Ohio State University Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study examined how nicotine pouches (like ZYN and Rogue) affect people who use smokeless tobacco in rural Ohio and Appalachia. Researchers measured nicotine levels in the blood and asked participants about their intentions to use these products. The goal was to understand whether nicotine pouches might become a popular alternative to traditional smokeless tobacco and what that could mean for public health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: nicotine pouches (ZYN and Rogue brands)
What this could lead to: If successful, this research could help public health officials understand whether nicotine pouches might help people switch from smokeless tobacco or lead to new nicotine addiction.
What could go wrong: This is an early-phase study with only 71 participants, so results may not apply to broader populations. It measures short-term effects and intentions, not long-term health outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TOBACCO-RELATED CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TOBACCO-RELATED CARCINOMA

Contacts and locations

Locations

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, 43210, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.